ET
Healthcare & Life Sciences
Elphis Cell Therapeutics
South Koreawww.elphiscellrx.com/
Elphis Cell Therapeutics is a Healthcare & Life Sciences startup based in South Korea, most recent round Series A, 1 tracked investor.
Activeseries-a
series-a
Stage
1
Investors
About Elphis Cell Therapeutics
Based in South Korea, Elphis Cell Therapeutics is a startup. Its most recent tracked round is Series A. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
Elphis Cell Therapeutics develops personalized cell therapies for vascular diseases using complex stem cells composed of vascular endothelial progenitor cells and mesenchymal stem cells to promote blood vessel regeneration and symptomatic relief.
Explore Elphis Cell Therapeutics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.